Difference between revisions of "RENIN ANGIOTENSIN SYSTEM-ANGIOTENSIN II"
(Imported from text file) |
(Imported from text file) |
||
Line 12: | Line 12: | ||
==Reference(s)== | ==Reference(s)== | ||
Barrett, K.E., Barman, S.M | Barrett, K.E., Barman, S.M., Brooks, H.L., X, J. and Ganong, W.F. (2019). Ganong’s review of medical physiology. 26th ed. New York: Mcgraw-Hill Education | ||
[[Category:Renin Angiotensin System]] | [[Category:Renin Angiotensin System]] | ||
[[Category:Physiology]] | [[Category:Physiology]] |
Latest revision as of 02:30, 21 March 2023
SUMMARY
BINDING TO TYPE I RECEPTORS
1. Vasoconstriction of efferent and afferent glomerular arterioles and interlobular artery ⟹ reduction in renal blood flow ⟹ elevation in hydraulic pressure in glomerular capillary ⟹ maintain GFR when RAS is activated by fall in systemic BP.
2. Inflammatory mediator: proinflammatory effect on leukocytes, endothelial cells and vascular smooth-muscle cells.
3. Proliferation of vascular smooth-muscle cells that can potentially increase atherogenesis.
BINDING TO TYPE II RECEPTORS
4. Counteract the classical actions: vasodilation and natriuresis, protects against target-organ damage and HTN.
Reference(s)
Barrett, K.E., Barman, S.M., Brooks, H.L., X, J. and Ganong, W.F. (2019). Ganong’s review of medical physiology. 26th ed. New York: Mcgraw-Hill Education